Delivery Order SPE2DB22D2214-SPE2DB24FS3AE
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,491.83 firm fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Pen, 3mL, a diabetes medication. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any special type of business. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award, valued at $1,097.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4568076279 INSULIN ASPART 100 UNIT/ML VL 10ML, with a firm fixed price and an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,474.68 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML, a critical medical commodity used in the treatment of diabetes. The contract has an ultimate completion date of May 1, 2024 and was awarded on April 30, 2024. This delivery order is part of a larger $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order valued at $6,102.16 for INSULIN ASPART 100 UNIT/ML VL 10ML. The award was made by the Defense Logistics Agency (DLA), which is the primary logistics and material distribution provider for the U.S. military. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,212.02 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL, with a performance period ending on April 10, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a broad...
- This federal contract award is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,484.56 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 29, 2024. The contract has an ultimate completion date of August 30, 2024 and is not designated as a set-aside. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,171.57 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Vial, 10mL. The contract has an ultimate completion date of August 23, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,145.34 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL vials. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military treatment...
- This federal contract award, valued at $7,553.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of insulin aspart 100 unit/mL vials, with a period of performance extending through April 2025. The contract is not designated as a set-aside and is therefore open to competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,088.30 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 unit/mL pens. This order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS3AEDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,610.83 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML medical products. The contract has an ultimate completion date of December 26, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be issued against that larger IDC contract. The award did not utilize any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 12/22/23 |